ADARx Pharmaceuticals, Inc.

NASDAQ:ADRX

Biotechnology

Healthcare
$12.82 +0.73%

+$0.13 today

Market cap
$1.42B
Beta
0.00
52W Low $16.64High $23.21

Volume 0.65M

Average 1.06M

ADRX Income Before Tax

Profit after all operating and non-operating items but before income tax.

No reported Income Before Tax figures are available to summarize.

Income Before Tax history

Currency unavailable · from the income statement

No Income Before Tax data reported for this period type.

Income Before Tax vs competitors

How ADRX compares with its peers on the latest reported figures

ADRX Competitors
Income Before Tax for ADRX and competitors
Company Period LTM YoY 3-year CAGR% of revenue
PRQRProQR Therapeutics N.V.LTM Mar 2026-€45.61M EUR-50.1%—339.3%
BNTCBenitec Biopharma Inc.LTM Mar 2026-$48.88M USD-44.5%——
RNAAtrium Therapeutics, Inc.FY2025-$76.83M USD——412.6%
ARCTArcturus Therapeutics Holdings Inc.LTM Mar 2026-$78.67M USD-14.7%—173.5%
SLNSilence Therapeutics plcLTM Mar 2026-$85.16M USD——9241.5%
MGTXMeiraGTx Holdings plcLTM Mar 2026-$120.53M USD+28.0%—151.1%
STOKStoke Therapeutics, Inc.LTM Mar 2026-$171.05M USD-431.8%—533.2%
WVEWave Life Sciences Ltd.LTM Mar 2026-$183.59M USD-63.4%—255.7%
PRMEPrime Medicine, Inc.LTM Mar 2026-$198.37M USD+1.9%—4917.6%
ADRXADARx Pharmaceuticals, Inc.—— ———
Peer median (excluding ADRX) —-44.5%—376.0%

Competitors are the stored peer set for ADRX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

ADARx Pharmaceuticals, Inc.

NASDAQ:ADRX

Intrinsic Alpha fair value

Locked

Current Price

$12.82

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.